134 related articles for article (PubMed ID: 38171149)
1. Design, synthesis, and biological evaluation of novel discoidin domain receptor inhibitors for the treatment of lung adenocarcinoma and pulmonary fibrosis.
Liu S; Li X; Chen C; Lin X; Zuo W; Peng C; Jiang Q; Huang W; He G
Eur J Med Chem; 2024 Feb; 265():116100. PubMed ID: 38171149
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo.
Tao J; Zhang M; Wen Z; Wang B; Zhang L; Ou Y; Tang X; Yu X; Jiang Q
Biomed Pharmacother; 2018 Oct; 106():1727-1733. PubMed ID: 30119248
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of collagen-induced discoidin domain receptor 1 and 2 activation by imatinib, nilotinib and dasatinib.
Day E; Waters B; Spiegel K; Alnadaf T; Manley PW; Buchdunger E; Walker C; Jarai G
Eur J Pharmacol; 2008 Dec; 599(1-3):44-53. PubMed ID: 18938156
[TBL] [Abstract][Full Text] [Related]
4. Discoidin domain receptor 1-deficient mice are resistant to bleomycin-induced lung fibrosis.
Avivi-Green C; Singal M; Vogel WF
Am J Respir Crit Care Med; 2006 Aug; 174(4):420-7. PubMed ID: 16690978
[TBL] [Abstract][Full Text] [Related]
5. Suppression of discoidin domain receptor 1 by RNA interference attenuates lung inflammation.
Matsuyama W; Watanabe M; Shirahama Y; Hirano R; Mitsuyama H; Higashimoto I; Osame M; Arimura K
J Immunol; 2006 Feb; 176(3):1928-36. PubMed ID: 16424224
[TBL] [Abstract][Full Text] [Related]
6. Discoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosis.
Matsuyama W; Watanabe M; Shirahama Y; Mitsuyama H; Higashimoto I; Osame M; Arimura K
Am J Pathol; 2006 Mar; 168(3):866-77. PubMed ID: 16507902
[TBL] [Abstract][Full Text] [Related]
7. Discoidin domain receptor 1 (DDR1) kinase as target for structure-based drug discovery.
Kothiwale S; Borza CM; Lowe EW; Pozzi A; Meiler J
Drug Discov Today; 2015 Feb; 20(2):255-61. PubMed ID: 25284748
[TBL] [Abstract][Full Text] [Related]
8. Structure-Based Design of Tetrahydroisoquinoline-7-carboxamides as Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors.
Wang Z; Bian H; Bartual SG; Du W; Luo J; Zhao H; Zhang S; Mo C; Zhou Y; Xu Y; Tu Z; Ren X; Lu X; Brekken RA; Yao L; Bullock AN; Su J; Ding K
J Med Chem; 2016 Jun; 59(12):5911-6. PubMed ID: 27219676
[TBL] [Abstract][Full Text] [Related]
9. Virtual screening for potential discoidin domain receptor 1 (DDR1) inhibitors based on structural assessment.
Xie J; Meng D; Li Y; Li R; Deng P
Mol Divers; 2023 Oct; 27(5):2297-2314. PubMed ID: 36322341
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel dasatinib analogues as potent DDR1 and DDR2 kinase inhibitors.
Liu L; Hussain M; Luo J; Duan A; Chen C; Tu Z; Zhang J
Chem Biol Drug Des; 2017 Mar; 89(3):420-427. PubMed ID: 27589335
[TBL] [Abstract][Full Text] [Related]
11. Collagen I induces discoidin domain receptor (DDR) 1 expression through DDR2 and a JAK2-ERK1/2-mediated mechanism in primary human lung fibroblasts.
Ruiz PA; Jarai G
J Biol Chem; 2011 Apr; 286(15):12912-23. PubMed ID: 21335558
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of discoidin domain receptors by imatinib prevented pancreatic fibrosis demonstrated in experimental chronic pancreatitis model.
Bansod S; Saifi MA; Godugu C
Sci Rep; 2021 Jun; 11(1):12894. PubMed ID: 34145346
[TBL] [Abstract][Full Text] [Related]
13. Discoidin Domain Receptor 1 Inhibitors: Advances and Future Directions for Novel Therapeutics with Aid of DNA Encoded Library Screens and Artificial Intelligence.
Sanawar R; Sahayasheela VJ; Sarath P; Dan VM
Mini Rev Med Chem; 2023; 23(15):1507-1513. PubMed ID: 36698236
[TBL] [Abstract][Full Text] [Related]
14. Emodin ameliorates bleomycin-induced pulmonary fibrosis in rats by suppressing epithelial-mesenchymal transition and fibroblast activation.
Guan R; Wang X; Zhao X; Song N; Zhu J; Wang J; Wang J; Xia C; Chen Y; Zhu D; Shen L
Sci Rep; 2016 Oct; 6():35696. PubMed ID: 27774992
[TBL] [Abstract][Full Text] [Related]
15. Discoidin domain receptors in disease.
Borza CM; Pozzi A
Matrix Biol; 2014 Feb; 34():185-92. PubMed ID: 24361528
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a novel DDRs kinase inhibitor XBLJ-13 for the treatment of idiopathic pulmonary fibrosis.
Dong Y; Tang BX; Wang Q; Zhou LW; Li C; Zhang X; Sun DD; Sun X; Zhang XM; Xiong B; Li J; Shi H; Chen DQ; Zang Y
Acta Pharmacol Sin; 2022 Jul; 43(7):1769-1779. PubMed ID: 34819618
[TBL] [Abstract][Full Text] [Related]
17. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
[TBL] [Abstract][Full Text] [Related]
18. Discoidin domain receptor 1 is associated with poor prognosis of non-small cell lung carcinomas.
Yang SH; Baek HA; Lee HJ; Park HS; Jang KY; Kang MJ; Lee DG; Lee YC; Moon WS; Chung MJ
Oncol Rep; 2010 Aug; 24(2):311-9. PubMed ID: 20596615
[TBL] [Abstract][Full Text] [Related]
19. Discovery of 4-amino-1H-pyrazolo[3,4-d]pyrimidin derivatives as novel discoidin domain receptor 1 (DDR1) inhibitors.
Dong R; Zhou X; Wang M; Li W; Zhang JY; Zheng X; Tang KX; Sun LP
Bioorg Med Chem; 2021 Jan; 29():115876. PubMed ID: 33246255
[TBL] [Abstract][Full Text] [Related]
20. Structural mechanisms determining inhibition of the collagen receptor DDR1 by selective and multi-targeted type II kinase inhibitors.
Canning P; Tan L; Chu K; Lee SW; Gray NS; Bullock AN
J Mol Biol; 2014 Jun; 426(13):2457-70. PubMed ID: 24768818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]